NZ199468A - Process for the preparation of 4-aminobutyramide (gabamide) - Google Patents

Process for the preparation of 4-aminobutyramide (gabamide)

Info

Publication number
NZ199468A
NZ199468A NZ199468A NZ19946882A NZ199468A NZ 199468 A NZ199468 A NZ 199468A NZ 199468 A NZ199468 A NZ 199468A NZ 19946882 A NZ19946882 A NZ 19946882A NZ 199468 A NZ199468 A NZ 199468A
Authority
NZ
New Zealand
Prior art keywords
process according
aminobutyramide
nitrobutyramide
preparation
hydrogenation
Prior art date
Application number
NZ199468A
Inventor
J Gosteli
M Mangane
G Rossey
A Wick
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NZ199468A publication Critical patent/NZ199468A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

1. A process for the preparation of 4-aminobutyramide characterized in that 4-nitrobutyramide is reduced by hydrogenation in the presence of a catalyst.

Description

New Zealand Paient Spedficaiion for Paient Number 1 99468 1 99468 If-1 >%! I >23.
Priority Dat&(s): .
CompSste Specification Fi5ed.
Class: .CP.lC.m -gl" MAV 19i 'hs8 PubHcctxri L'^ts: UvJ NEW ZEALAND N/347 25- PATENTS ACT 1953 PATENTS FORM NO. 3 COMPLETE SPECIFICATION "PROCESS FOR THE PREPARATION OF 4-AMINOBUTYRAMIDE" WE, SYNTHELABO, a French Body Corporate, of 58 rue de la Glaciere, 75621 Paris Cedex 13, France, hereby declare the invention for which we pray that a patent may be granted to us and the method by which it is to be performed, to be particularly described in and by the following statement: (followed by page la) \ 1 9946 - la-DESCRIPTION "PROCESS FOR THE PREPARATION OF 4-AMINOBUTYRAMIDE" The present invention relates to a new process for the preparation of gabamide.
Various preparations of gabamide, or 4-amino-butyramide, have already been described in the literature: in particular, the article in Angew.
Chem. Int. Ed. 19_ (1980), page 627, describes the selective hydrogenation of 3-cyanopropionamide in the presence of hydrogen chloride.
The present invention relates to an economical process which leads to gabamide with a very good yield. The process of the invention is illustrated in the following scheme: nh4oh/nh4ci N02-CH2-CH2-CH2-C00Alkyl ^NC>2-CH2-CH2-CH2-CONH2 [h]/hci NH2-CH2-CH2-CH2-CONH2 The starting compound, namely an alkyl 4-nitrobutanoate, more particularly methyl 4-nitrobutanoate, is described in J. Org. Chem. 1962, 1609. 1 9 94 The first step of the process consists in converting the alkyl 4-nitrobutanoate to 4-nitrobutyramide by any suitable means for converting an ester to an amide, for example by aminolysis, 5 in particular in the presence of ammonia solution and ammonium chloride. 4-Nitrobutyramide is known and has been prepared by a different method, also described in J. Org. Chem. 1962, 1609.
The reduction of 4-nitrobutyramide to 10 4-aminobutyramide, which is the key step in the process of the present invention, is carried out by any suitable means for reducing the nitro radical to the amino radical. It can be carried out, in particular, by hydrogenation in the presence of a catalyst and an 15 acid (preferably an inorganic acid), under a pressure ranging, for example, from 1 to 10 bars, and at a temperature ranging from 0 to 50°C.
The hydrogenation catalysts are, for example, platinum oxide (Pt02) or Raney nickel. 20 The preferred acid is hydrochloric acid.
The following Example illustrates the invention. 1. 4-NITROBUTYRAMIDE In a 500 ml Erlenmeyer flask, 15 g (0.102 mol) 25 of methyl 4-nitrobutanoate are introduced into 60 ml of ammonia solution (density: 0.92) and 1.5 g (0.03 mol) of 19 94 ammonium chloride. The mixture is stirred overnight by means of a magnetic stirrer at the temperature of the laboratory. The solution is concentrated in vacuo at 45-50°C. The residue is taken up in 200 ml of ethyl acetate and the solution is filtered to remove the salts therefrom. A small amount of activated charcoal is added, the mixture is filtered and the solution is concentrated to a third of the initial volume. The product crystallises in the form of white crystals.
Melting point = 89°C (Kofler); 88-89°C (Tottoli: l°C/minute).
Yield: 13.47 g (100%).
The IR and NMR spectra are consistent. 2. 4-AMINOBUTYRAMIDE (HYDROCHLORIDE) 0.25 g (1.9 millimols) of 4-nitrobutyramide, 20 ml of methanol, 5 ml of IN hydrochloric acid and 0.0 2 g of platinum oxide (Pt02) are introduced into a Parr bomb. The mixture is agitated for 2 hours at 20°C under hydrogen (4 bars). The platinum is filtered off and the solution is concentrated. The residual mass is taken up in 5 ml of ethanol. 20 ml of ethyl acetate are then added to the solution. The crystalline product is filtered off and dried.
Melting point = 139-140°C (Kofler); 138°C (Tottoli: l°C/minute).
Yield: 0.218 g (98%). 1 994 _ 4 - The IR and NMR .spectra are identical to those of the authentic product.
The process of the invention makes it possible to obtain gabamide with a very good yield and economically, gabamide being a product known for its psychotropic properties and a starting material for syntheses which lead to benzylidene derivatives having very valuable pharmacological properties. 1994

Claims (11)

WHAT WE CLAIM IS:
1. Process for the preparation of 4-aminobutyramide which comprises reducing the nitro radical of 4-nitrobutyramide to the primary amino radical.
2. Process according to claim 1 in which r reduction of the nitro radical is effected by hydrogenation in the presence of a catalyst.
3. Process according to claim 2 in which the catalyst is platinum oxide or Raney nickel.
4. Process according to claim 3 in which the hydrogenation is carried out in the presence of platinum oxide and an acid.
5. Process according to claim 4 in which the acid is hydrochloric acid.
6. Process according to any one of claims 2 to 5 in which the catalytic hydrogenation of 4-nitrobutyramide is carried out under a pressure ranging from 1 to 10 bars and at a temperature ranging from 0 to 50°C.
7. Process according to claim 1 in which the 4-nitrobutyramide is obtained from an alkyl 4-nitrobutanoate. 1 99468 - 6 -
8. Process according to claim 7 in which an alkyl 4-nitrobutanoate is converted to 4-nitrobutyramide by aminolysis.
9. Process according to claim 8 in which the aminolysis is carried out using ammonia solution and ammonium chloride.
10. Process for the preparation of 4-aminobutyramide according to claim 1 substantially as described in the foregoing Example.
11. 4-Aminobutyramide when prepared by the process claimed in any one of the preceding claims. SVNrrH^ lR So By Hts/thelr authorised Agents., A. J. PARK & SON.
NZ199468A 1981-01-13 1982-01-12 Process for the preparation of 4-aminobutyramide (gabamide) NZ199468A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8100440A FR2497797A1 (en) 1981-01-13 1981-01-13 PROCESS FOR THE PREPARATION OF AMINO-4 BUTYRAMIDE

Publications (1)

Publication Number Publication Date
NZ199468A true NZ199468A (en) 1984-05-31

Family

ID=9254051

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ199468A NZ199468A (en) 1981-01-13 1982-01-12 Process for the preparation of 4-aminobutyramide (gabamide)

Country Status (16)

Country Link
EP (1) EP0056343B1 (en)
JP (1) JPS57139046A (en)
AT (1) ATE6933T1 (en)
AU (1) AU7945582A (en)
DE (1) DE3260086D1 (en)
DK (1) DK10082A (en)
ES (1) ES8502080A1 (en)
FI (1) FI820092L (en)
FR (1) FR2497797A1 (en)
GR (1) GR75180B (en)
IE (1) IE52513B1 (en)
IL (1) IL64760A0 (en)
NO (1) NO820073L (en)
NZ (1) NZ199468A (en)
PT (1) PT74274A (en)
ZA (1) ZA82185B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102548954B (en) * 2009-10-06 2014-04-16 拜耳作物科学公司 Method for producing 2,2-difluoroethylamine by hydrogenating 1,1-difluoro-2-nitroethane

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1225419A (en) * 1958-07-29 1960-06-30 Montedison Spa Process for the preparation of omega-aminocaprylic acid amide and products obtained by this process
DE2316459C2 (en) * 1973-04-03 1982-06-24 Hoechst Ag, 6000 Frankfurt Process for the preparation of 1-nitrobenzene-2-carboxylic acid alkyl ester-5-carboxamides
DE2319360A1 (en) * 1973-04-17 1974-11-07 Basf Ag PROCESS FOR THE PRODUCTION OF EPSILONAMINOCAPRONIC ACID AMIDE

Also Published As

Publication number Publication date
ZA82185B (en) 1983-01-26
IE52513B1 (en) 1987-11-25
FI820092L (en) 1982-07-14
GR75180B (en) 1984-07-13
EP0056343B1 (en) 1984-04-04
JPS57139046A (en) 1982-08-27
EP0056343A1 (en) 1982-07-21
IL64760A0 (en) 1982-03-31
NO820073L (en) 1982-07-14
ES508656A0 (en) 1984-12-01
ES8502080A1 (en) 1984-12-01
FR2497797A1 (en) 1982-07-16
IE820049L (en) 1982-07-13
DE3260086D1 (en) 1984-05-10
ATE6933T1 (en) 1984-04-15
AU7945582A (en) 1982-07-22
DK10082A (en) 1982-07-14
FR2497797B1 (en) 1983-12-23
PT74274A (en) 1982-02-01

Similar Documents

Publication Publication Date Title
US7531673B2 (en) Preparation of amino acid amides
SU1428194A3 (en) Method of producing (r)-alpha-ethyl-2-oxo-1-pyrrolidine-acetamide
JPH06271549A (en) Piperazine derivative
KR100464180B1 (en) NEW PROCESS FOR THE PREPARATION OF 11-AMINO-3-CHLORO-6,11-DIHYDRO-5,5-DIOXO-6-METHYL-DIBENZO[c,f][1,2]THIAZEPINE AND APPLICATION TO THE SYNTHESIS OF TIANEPTINE
Butula et al. Reactions with 1-benzotriazolecarboxylic acid chloride. VIII. Synthesis of N-hydroxyisocyanate derivatives
KR0133286B1 (en) Process for preparing 3-pyrrolidinol
NZ199468A (en) Process for the preparation of 4-aminobutyramide (gabamide)
NZ238526A (en) Preparation of indapamide
Wulff et al. Preparation of novel heterocyclic amino acids from N-(arylmethylene) dehydroalanine methyl esters
KR100303593B1 (en) Process for the preparation of pyridyl methyl aminotriazinone
EP1044976B1 (en) Process for the preparation of pirlindole hydrochloride
US4454120A (en) Analgesic dipeptide amides and method of use and compositions thereof
EP1215206A1 (en) Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
US3030378A (en) Five-membered nu-heterocyclic guanidines
Eustache et al. Conformationally constrained no synthase inhibitors: Rigid analogs of LN-iminoethylornithine
Lee et al. Selective reduction of secondary amides to amines in the presence of tertiary amides
US4533655A (en) Analgesic dipeptide amides and method of use and compositions thereof
CN108602758B (en) Process for preparing trans-4-amino-1-cyclohexanecarboxylic acids and derivatives thereof
EP1347958B1 (en) Process for preparing distamycin derivatives
CA2506564C (en) An improved process for the preparation of gabalactam
KR0150002B1 (en) Thienylacetic acid derivatives, and pharmaceuticals containing them
AU2002220696A1 (en) Process for preparing distamycin derivatives
EP0784608B1 (en) The manufacture of levobupivacaine and analogues thereof from l-lysine
EP0345711B1 (en) Process for the preparation of pyrrolizine derivatives
CA1193249A (en) N-substituted ergoline- and 9,10-didehydro-ergoline-8- carboxamide-and 8-aminomethyl-derivatives, their production and their pharmaceutical composition